Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 55 pages
Exam (elaborations)

APEA Pharmacology Final Exam (Latest 2026) with questions and answers with rationales/graded A+/2026 update/100% correct

Document preview thumbnail
Preview 4 out of 55 pages

APEA Pharmacology Final Exam (Latest 2026) with questions and answers with rationales/graded A+/2026 update/100% correct

Content preview

APEA Pharmacology Final Exam
(Latest 2026) with questions and answers
with rationales/graded A+/2026
update/100% correct

Cardiovascular & Hematologic Pharmacology

1. A 62-year-old African American male with hypertension and stage 3
chronic kidney disease (CKD) presents for follow-up. His BP is 148/90
mmHg. Which antihypertensive regimen is MOST appropriate as first-
line therapy given his comorbid conditions?

• A) Hydrochlorothiazide 25 mg daily
• B) Lisinopril 10 mg daily
• C) Metoprolol 50 mg daily
• D) Amlodipine 5 mg daily

Correct Answer: B

Rationale: ACE inhibitors (like lisinopril) are first-line for
hypertension, especially in patients with CKD due to their
renoprotective effects (reducing intraglomerular pressure). While
thiazides are first-line for general HTN, they are less effective in
advanced CKD (eGFR <30). Beta-blockers are not first-line without
another compelling indication. CCBs are options but do not provide the
same renal protection as RAAS blockade.



2. A patient with non-valvular atrial fibrillation (CHADS-VASc score of
4) is currently taking warfarin. He asks about switching to apixaban

,(Eliquis) to avoid dietary restrictions. What is a primary advantage of
apixaban over warfarin?

• A) No requirement for routine INR monitoring
• B) Reversal agent is widely available over-the-counter
• C) Lower cost than warfarin
• D) Safe to use in mechanical heart valves

Correct Answer: A

Rationale: Direct Oral Anticoagulants (DOACs) like apixaban have
predictable pharmacokinetics and do not require routine INR
monitoring. DOACs are contraindicated in mechanical heart valves.
Vitamin K is the reversal agent for warfarin; andexanet alfa is expensive
and used for specific DOACs. Warfarin is generally much cheaper.



3. Which medication is associated with the adverse effect of a persistent,
dry, hacking cough that resolves upon discontinuation?

• A) Losartan
• B) Lisinopril
• C) Metoprolol
• D) Amlodipine

Correct Answer: B

Rationale: Angiotensin-converting enzyme (ACE) inhibitors (lisinopril,
enalapril) commonly cause a dry cough due to the accumulation of
bradykinin in the lungs. ARBs (losartan) have a significantly lower
incidence of cough. Beta-blockers cause fatigue/bradycardia; CCBs
cause edema.

,4. A patient is prescribed furosemide (Lasix) 40 mg BID for heart
failure. Which laboratory finding requires the most immediate
intervention?

• A) Sodium 135 mEq/L
• B) Creatinine 1.1 mg/dL
• C) Potassium 2.9 mEq/L
• D) BUN 18 mg/dL

Correct Answer: C

Rationale: Loop diuretics cause significant renal excretion of
potassium, leading to hypokalemia. A potassium of 2.9 mEq/L increases
the risk of fatal cardiac arrhythmias (especially if the patient is also on
digoxin) and requires immediate repletion.



5. A patient on Digoxin presents with nausea, vomiting, blurred vision
(yellow halos), and a heart rate of 45 bpm. Which electrolyte imbalance
most likely precipitated this toxicity?

• A) Hypernatremia
• B) Hypokalemia
• C) Hypercalcemia
• D) Hypomagnesemia

Correct Answer: B

Rationale: Hypokalemia increases the binding of digoxin to the sodium-
potassium ATPase pump, leading to toxicity even at normal serum
levels. Low potassium enhances the toxic effects of digoxin on cardiac
conduction and automaticity.

, 6. Which of the following is the antidote of choice for a patient with life-
threatening bleeding due to apixaban (Eliquis)?

• A) Protamine Sulfate
• B) Vitamin K
• C) Andexanet alfa
• D) Naloxone

Correct Answer: C

Rationale: Andexanet alfa (Andexxa) is a recombinant modified human
factor Xa decoy protein that binds and sequesters apixaban and
rivaroxaban. Protamine reverses heparin. Vitamin K reverses warfarin.


Respiratory & Immunology

7. According to the 2026 GINA guidelines, what is the preferred reliever
medication for an adult with mild intermittent asthma?

• A) Low-dose ICS-formoterol (as needed)
• B) Albuterol (SABA) as needed
• C) Oral montelukast daily
• D) High-dose ICS daily

Correct Answer: B

Rationale: While guidelines are shifting toward ICS-formoterol for mild
persistent asthma, for intermittent asthma (symptoms <2 days/week),
as-needed short-acting beta-agonist (SABA) such as albuterol remains
the standard rescue therapy. However, the search results emphasize that
for persistent asthma, ICS-formoterol is preferred to reduce severe
exacerbations.

Document information

Uploaded on
September 6, 2026
Number of pages
55
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$23.00

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
4
Followers
0
Items
287
Last sold
1 week ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions